Corrigendum to “A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation”

---

In the article titled “A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation” [1], the number of probiotics in the formulation mixtures in subsection “2.1. Study Design” in Materials and Methods was written incorrectly as follows:

“The composition of the probiotic mix F_1 was as follows: 5 × 10⁹ CFU L. acidophilus (30 mg as lyophilized), 5 × 10⁹ CFU L. reuteri (30 mg as lyophilized), 330 mg inulin, 5 mg silica, and 5 mg talc. The F_2 composition was as follows: 5 × 10⁹ CFU L. plantarum (12 mg as lyophilized), 5 × 10⁹ CFU L. rhamnosus (20 mg as lyophilized), 5 × 10⁹ CFU B. animalis subsp. lactis (60 mg as lyophilized), 298 mg inulin, 5 mg silica, and 5 mg talc. Placebo (F_3) composition was as follows: 390 mg inulin, 5 mg silica, 5 mg talc.”

It should be corrected to the following: “The composition of the probiotic mix F_1 was as follows: 2 × 10⁹ CFU L. acidophilus (30 mg as lyophilized), 2 × 10⁹ CFU L. reuteri (30 mg as lyophilized), 330 mg inulin, 5 mg silica, and 5 mg talc. The F_2 composition was as follows: 2 × 10⁹ CFU L. plantarum (12 mg as lyophilized), 2 × 10⁹ CFU L. rhamnosus (20 mg as lyophilized), 2 × 10⁹ CFU B. animalis subsp. lactis (60 mg as lyophilized), 298 mg inulin, 5 mg silica, and 5 mg talc. Placebo (F_3) composition was as follows: 390 mg inulin, 5 mg silica, and 5 mg talc.”